摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,4-二甲基-2,3-二氢-1-苯并呋喃 | 153782-72-0

中文名称
2,4-二甲基-2,3-二氢-1-苯并呋喃
中文别名
——
英文名称
2,3-dihydro-2,4-dimethylbenzofuran
英文别名
2,4-Dimethyl-2,3-dihydro-1-benzofuran
2,4-二甲基-2,3-二氢-1-苯并呋喃化学式
CAS
153782-72-0
化学式
C10H12O
mdl
——
分子量
148.205
InChiKey
YOIIMWIPUXHZLB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2,4-二甲基-2,3-二氢-1-苯并呋喃盐酸 、 titanium(III) chloride 、 硝酸 作用下, 以 四氯化碳溶剂黄146 为溶剂, 反应 5.0h, 生成 5-amino-2,3-dihydro-2,4-dimethylbenzofuran hydrochloride
    参考文献:
    名称:
    The fischer indolisation reaction and the synthesis of dihydroindenoindoles
    摘要:
    The Fischer reaction between indanones and certain alkoxyarylhydrazines fails; the indanones are returned unreacted and the arylhydrazines are converted into the corresponding alkoxy-2-chloroarylamines and other products. A new N-amination route to arylhydrazines from the arylamines has been developed and it has been demonstrated that problems with the indolisation of alkoxyarylhydrazones can be circumvented by ring closures of their O-tosylated analogues. Some results using the Lepke synthesis of indoles are recorded.
    DOI:
    10.1016/s0040-4020(01)81911-6
  • 作为产物:
    描述:
    2,4-dimethyl-5-nitro-2,3-dihydrobenzo<2,3>furan盐酸 、 sodium dithionate 、 titanium(III) chloride 、 sodium nitrite 作用下, 以 盐酸溶剂黄146 为溶剂, 反应 3.17h, 生成 2,4-二甲基-2,3-二氢-1-苯并呋喃
    参考文献:
    名称:
    The fischer indolisation reaction and the synthesis of dihydroindenoindoles
    摘要:
    The Fischer reaction between indanones and certain alkoxyarylhydrazines fails; the indanones are returned unreacted and the arylhydrazines are converted into the corresponding alkoxy-2-chloroarylamines and other products. A new N-amination route to arylhydrazines from the arylamines has been developed and it has been demonstrated that problems with the indolisation of alkoxyarylhydrazones can be circumvented by ring closures of their O-tosylated analogues. Some results using the Lepke synthesis of indoles are recorded.
    DOI:
    10.1016/s0040-4020(01)81911-6
点击查看最新优质反应信息

文献信息

  • C- ARYL GLYCOSID DERIVATIVES, PHARMACEUTICAL COMPOSITION, PREPARATION PROCESS AND USES THEREOF
    申请人:SHANGHAI DE NOVO PHARMATECH CO. LTD.
    公开号:US20170037038A1
    公开(公告)日:2017-02-09
    This invention relates to a kind of C-aryl glycoside derivatives, its pharmaceutical compositions, preparation methods, and uses thereof. The preparation method comprises: method 1: in a solvent, deprotecting the acetyl protecting groups of compound 1-f in the presence of a base; method 2: 1) compound 2-g reacts with via Mitsunobu reaction; 2) deprotecting the acetyl protecting groups of compound 2-f obtained from step 1; method 3: 1) compound 2-g reacts with via nucleophilic substitution reaction; 2) deprotecting the acetyl protecting groups of compound 3-f obtained from step 1. The pharmaceutical composition comprises a kind of C-aryl glycoside derivatives; it's pharmaceutically acceptable salts and/or prodrugs thereof and excipient thereof. This invention further relates to a kind of C-aryl glycoside derivatives, it's pharmaceutically acceptable salts or pharmaceutical compositions thereof for the use in preparation of a SGLT inhibitor. The C-aryl glycoside derivatives of this invention provides a new direction for the study of SGLT inhibitors.
    这项发明涉及一种C-芳基糖苷衍生物,其药物组合物、制备方法及其用途。制备方法包括:方法1:在溶剂中,在碱的存在下去保护化合物1-f的乙酰保护基;方法2:1)化合物2-g通过Mitsunobu反应发生反应;2)去除从步骤1得到的化合物2-f的乙酰保护基;方法3:1)化合物2-g通过亲核取代反应发生反应;2)去除从步骤1得到的化合物3-f的乙酰保护基。药物组合物包括一种C-芳基糖苷衍生物;其药学上可接受的盐和/或前药以及赋形剂。这项发明还涉及一种C-芳基糖苷衍生物,其药学上可接受的盐或其药物组合物,用于制备SGLT抑制剂。这项发明的C-芳基糖苷衍生物为SGLT抑制剂的研究提供了新的方向。
  • AMIDE COMPOUND
    申请人:Setoh Masaki
    公开号:US20100041891A1
    公开(公告)日:2010-02-18
    A compound having GPR52 agonist activity or a salt thereof is provided. The compound can be provided as a preventive/therapeutic agent for schizophrenia or the like. The compound is represented by the following formula: wherein A represents —CONR a — or —NR a CO—, R a represents a hydrogen atom or the like, B represents a hydrogen atom or the like, a ring Cy1 represents a six-membered aromatic ring which may have one or more substituents in addition to a group represented by -A-B, a ring Cy2 represents a six-membered ring which may be substituted with a halogen atom or the like, a ring Cy3 represents a five- or six-membered ring which may have one or more substituents; X represents C 1-2 alkylene or the like, m represents an integer of 0 to 2, and a ring Cy4 represents a six-membered aromatic ring which may have one or more substituents.
    提供具有GPR52激动剂活性或其盐的化合物。该化合物可作为预防/治疗精神分裂症等疾病的药物。该化合物由以下公式表示:其中A代表—CONRa—或—NRaCO—,Ra代表氢原子或类似物质,B代表氢原子或类似物质,环Cy1代表一个六元芳香环,除了由-A-B表示的基团外,可能有一个或多个取代基,环Cy2代表一个六元环,可能被卤素原子或类似物质取代,环Cy3代表一个有一个或多个取代基的五元或六元环;X代表C1-2烷基或类似物质,m代表0到2之间的整数,环Cy4代表一个六元芳香环,可能有一个或多个取代基。
  • METHOD FOR THE SYNTHESIS OF 4-BENZOFURAN-CARBOXYLIC ACID
    申请人:Burgos Alain
    公开号:US20090131688A1
    公开(公告)日:2009-05-21
    The invention concerns a novel method for synthesis of 4-benzofuran-carboxylic acid or alkyl ester thereof. This method is characterized in that a reaction for aromatization of a compound of formula (II) is performed for the synthesis of the compound of formula (I), according to the scheme A2 below: wherein R independently represents hydrogen or a linear or branched C 1 - 15 alkyl group. With the invention, it is possible to industrially synthesize 4-benzofuran-carboxylic acid or alkyl ester thereof with good yield and very good purity.
    该发明涉及一种合成4-苯并呋喃羧酸或其烷基酯的新方法。该方法的特点在于,根据下面的方案A2,对式(II)化合物进行芳香化反应以合成式(I)的化合物:其中R独立表示氢或直链或支链的C1-15烷基基团。通过这项发明,可以以良好的产率和非常高的纯度工业化合成4-苯并呋喃羧酸或其烷基酯。
  • Dihydrobenzofuran production from catalytic tandem Claisen rearrangement–intramolecular hydroaryloxylation of allyl phenyl ethers in subcritical water
    作者:Ligang Luo、Chunze Liu、Zhiqiang Hou、Yuanyuan Wang、Liyi Dai
    DOI:10.1039/c4ra04689g
    日期:——
    mild method for the preparation of dihydrobenzofurans through hydrothermal catalytic tandem Claisen rearrangement–intramolecular hydroaryloxylation of allyl phenyl ethers. This reaction provides a new method for constructing dihydrobenzofurans, a process that is potentially applicable to natural product synthesis. SBA-15, TS-1, HZSM-5 were chosen as catalysts in a hydrothermal reaction medium between 200
    我们在此报告了一种温和的方法,该方法通过水热催化串联Claisen重排-烯丙基苯基醚的分子内氢芳氧基化来制备二氢苯并呋喃。该反应提供了构建二氢苯并呋喃的新方法,该方法可能适用于天然产物的合成。选择SBA-15,TS-1,HZSM-5作为200-320°C水热反应介质中的催化剂。HZSM-5催化剂表现出最高的催化活性,研究了烯丙基苯基醚-水的摩尔比,时间,压力,温度和催化剂对水热条件下克莱森加氢芳氧基化反应的影响。后两个过程变量对产品的产量和分布影响最大。
  • 3-AZA-BICYCLO[3.3.0]OCTANE COMPOUNDS
    申请人:Aissaoui Hamed
    公开号:US20100184808A1
    公开(公告)日:2010-07-22
    The invention relates to 3-aza-bicyclo[3.3.0]octane derivatives of the formula (I) wherein R 1 , R 2 , R 3 , and A are as described in the description and their use as orexin receptor antagonists.
    本发明涉及3-aza-bicyclo [3.3.0]辛烷衍生物,其化学式为(I),其中R1,R2,R3和A如说明书所述,并将其用作促进醒觉素受体拮抗剂。
查看更多

同类化合物

黄曲霉毒素 D1 顺式-3alpha,8alpha-二氢-4,6-二甲氧基-呋喃并[2,3-b]苯并呋喃 阿莫拉酮 苯甲醇,-α--甲基-4-(2-甲基丙基)-,乙酸酯(9CI) 苯并呋喃,7-氯-2,3-二氢-2,2-二甲基- 苯并呋喃,4-氯-2,3-二氢- 苯并呋喃,2,3-二氢-3-[(苯基硫代)甲基]- 苯并二氢呋喃-4-甲醛 苯并二氢呋喃-4-甲酸 苯并二氢呋喃-2-羧酸 胆甾-8-烯-3,15-二醇,(3b,5a,15a)-(9CI) 盐酸依法洛沙 甲基氨基甲酸4-氯-2,3-二氢-2,2-二甲基苯并呋喃-7-基酯 甲基5-氨基-2,3-二氢-1-苯并呋喃-2-羧酸酯 甲基2-乙基-6-羟基-2,3-二氢-1-苯并呋喃-2-羧酸酯 甲基(2S)-2-乙基-2,3-二氢-1-苯并呋喃-2-羧酸酯 环丙基甲胺 灭草呋喃 氘代克百威(呋喃丹) 普芦卡必利杂质H 抗氧剂136 多特林中间体 呋草黄 呋罗芬酸 呋喃酚 十一碳烯 克百威 依法克生 他司美琼 人参宁 二苯基异壬基膦酸酯 二硫代双(甲基氨基甲酸)双(2,3-二氢-2,2-二甲基-7-苯并呋喃)酯 二[2,3-二氢-2,2-二甲基-7-苯并呋喃重氮鎓]硫酸盐 二-2,3-二氢-1-苯并呋喃-5-基乙酸 乙基3-(7-溴-2,3-二氢-1-苯并呋喃-5-基)丙酸酯 丙硫克百威 丁硫克百威 [2H4]-2,3-二氢-5-苯并呋喃乙醇 [2H18]-丁硫克百威 [2-[2-氧代-5-(2,4,4-三甲基戊烷-2-基)-3H-1-苯并呋喃-3-基]-4-(2,4,4-三甲基戊烷-2-基)苯基]乙酸酯 [2,3-二氢-1-苯并呋喃-3-基(苯基)甲基]-二甲基-苯基硅烷 [2,2-二甲基-7-(甲基氨基甲酰氧基)-3H-1-苯并呋喃-3-基](Z)-2-甲基丁-2-烯酸酯 N-甲基氨基甲酸2,3-二氢苯并呋喃-7-基酯 N-甲基氨基甲酸2,3-二氢-2,2,4-三甲基苯并呋喃-7-基酯 N-甲基-[(2,3-二氢苯并[b]呋喃-7-基)甲基]胺 N-甲基(2,3-二氢苯并呋喃-2-基)甲胺盐酸盐 N-亚硝基羰基呋喃 N-[[(2S)-1-乙基吡咯烷-2-基]甲基]-5-碘-2,3-二氢-1-苯并呋喃-7-甲酰胺 N-[(2,2-二甲基-2,3-二氢-1-苯并呋喃-7-基)甲基]-n-甲胺 N-(吗啉基硫基)呋喃丹